Blake Shirley

Stewardship Writer

Jennifer Schutzman

The 2010 Richard N. Merkin, MD – PCF Young Investigator Award

Jennifer Schutzman, MD, PhD:

University of California, San Francisco – San Francisco, CA

Mentor:

Gail Martin, PhD, Professor in the Department of Anatomy at the University of California, San Francisco.

Abhishek Srivastava

The 2011 LeFrak Family – PCF Young Investigator Award

Abhishek Srivastava, MD:

University of Michigan

Mentor:

Ashutosh Tewari, MD, PhD

Sumit Subudhi

2014 Stewart Rahr-PCF Young Investigator

Sumit Subudhi, MD, PhD:

M. D. Anderson Cancer Center

Mentors:

James Allison, PhD, Padmanee Sharma, MD, PhD

Proposal Title:

Improving Patient Selection for Immune Checkpoint Therapy: Maximizing Benefit and Minimizing Toxicities

Daniel Spratt

2014 Rebecca and Nathan Milikowsky-PCF Young Investigator

Daniel Spratt, MD:

University of Michigan

Mentors:

Charles Sawyers, MD

Proposal Title:

Androgen Receptor Signaling Post-Radiotherapy: A Novel Non-Invasive Predictive Biomarker for Locally Advanced and Castrate Resistant Prostate Cancer

Anirban Sahu

2014 Stewart Rahr-PCF Young Investigator

Anirban Sahu, PhD:

University of Michigan

Mentor:

Arul Chinnaiyan, MD, PhD

Proposal Title:

The Role of Long Noncoding RNA SChLAP1 in Aggressive Prostate Cancer

Karen Sfanos

The 2012 Chris and Felicia Evensen – PCF Young Investigator Award

Karen Sfanos, PhD:

Johns Hopkins University School of Medicine

Mentors:

Angelo deMarzo, MD, PhD and William Nelson, MD, PhD

Nicole Simone

2013 Ben Franklin-PCF Young Investigator

Nicole Simone, MD:

Thomas Jefferson University

Mentors:

Adam Dicker, MD, PhD, Karen Knudsen, PhD and Peter Carroll, MD

Project Title:

Metabolic approaches for targeting multiple components of the IGF-1R pathway in prostate cancer

Prasanna Sooriakumaran

2015 Howard Shore–PCF Young Investigator

Prasanna Sooriakumaran, MBBS, PhD:

University of Oxford

Mentor:

Freddie C. Hamdy, MD

Proposal Title:

Improving Quality of Care for Men with Skeletal Metastases from Prostate Cancer: Defining the Burden-of-Treatment and its Management, and Developing Models to Predict Quality-of-Life

Howard Scher

Howard Scher, MD –:

Memorial Sloan-Kettering Cancer Center
Development of Combined Inhibition of AR and PI3K Signaling as a Therapeutic Strategy for Advanced Prostate Cancer

Co-Investigators:

Charles Sawyers, MD; Brett Carver, MD; Neal Rosen, MD, PhD

Richard V. Sandler

Partner
Maron & Sandler
Executive Vice President
Milken Family Foundation

Jonathan W. Simons, MD

Chief Science Officer and Medical Director
Marcus Foundation